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Abstract
Background: Acute aortic dissection (AAD) is an event which may be rapidly fatal without early diagnosis and
treatment. Aging is one of the main risk factors that could leading to AAD. To date, no specific biomarkers are available
to increase the speed of diagnosis. CD40 ligand (CD40L), myeloperoxidase (MPO), matrix metalloproteinase (MMP)-1, -2,
-9 and metallopeptidase tissue inhibitor 1 (TIMP-1) are biologically related molecules which integrate inflammation,
tissue injury and remodeling, all events associated to AAD.
Our is a pilot study to evaluate whether circulating levels of these molecules may be used as potential biomarkers in
timely diagnosis of AAD.
Results: Within 24 h of symptom onset, circulating CD40L, MPO, MMP-1,-2,-9 and TIMP-1 were quantified by enzyme-
linked immunosorbent assays in 22 patients (40–86 years of age) with AAD of ascending aorta (type A according to
Stanford classification) and 11 patients with AAD of descending aorta (type B). 30 healthy individuals age matched
were used as control group compared to controls, both type A and B AAD patients had higher CD40L (p < 0.001) and
MPO (p < 0.01) levels. MMP-1 was higher in the overall AAD group (p < 0.01). After Stanford classification, type A group
had increased level compared to both control and type B (p < 0.01 and p < 0.05, respectively). TIMP-1 was higher in
both A and B groups compared to controls (p < 0.001). No differences were observed in MMP-2 and MMP-9 levels.
Conclusions: The simultaneous evaluation of CD40L, MPO and MMP-1 and TIMP-1, which may contribute to structural
changes in aortic tissue in AAD patients, seems to be a novel promising diagnostic panel.
Keywords: Acute aortic dissection (AAD), CD40 ligand (CD40L), Matrix metalloproteinases (MMPs), Metallopeptidase
tissue inhibitor 1 (TIMP-1), Myeloperoxidase (MPO)
Background
Acute aortic dissection (AAD) is a clinical condition
caused by a circumferential or, less frequently, transverse
tear of the intima. The initiating event is either a pri-
mary intimal tear with secondary dissection into the
media or a medial hemorrhage that dissects into and
disrupts the intima. The etiology of AAD is imputed to
either genetic disorders affecting connective tissue, such
as Marfan syndrome, or as a consequence of primary
disorders, generally called non-Marfan AAD [1, 2].
Aging is the main of all risk factors leading to AAD
including atherosclerosis or hypertension [3, 4]. Particu-
larly it has been known that patients with AAD under-
going to coronary by pass surgery with 40–86 years of
age range had a really dramatically decrease in the number
of interlaminar fibers and an increase of laminar distance
with aging [5, 6]. This pathway could result in a dilatation
of the aorta and incurs in AAD [7].
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In particular the pathophysiology of AAD was charac-
terized by degeneration of the aortic fascia, smooth
muscle cell (SMC) loss, inflammation, fragmentation
and depletion of elastic fibers [8, 9] that are key events
in AAD which may lead to recruitment of local T-cells
and macrophages as a primary response to endothelial
damage [9, 10]. These assumptions were well supported
in previous study focused on the identification of differ-
ent mechanisms that can contribute to the up-regulation
of genes involved in the endothelial turnover and also it
is well reported that a differential genetic profiles can be
related to aortic dissection development [11–13]. In fact
genomic alterations of enzymes involved into endothe-
lium turnover, as the metalloproteinases (MMPs), and
polymorphisms of their genes, were directly associated
to aortic degeneration due to the fact MMPs are deputed
to maintain elastin and collagen in aorta composition
during endothelial damage [14, 15].
Furthermore AAD may be rapidly fatal without early
diagnosis and treatment [16–18]. Among different medi-
ators that can be induced during endothelial turnover
after AAD lesion, CD40 ligand (CD40L), myeloperoxidase
(MPO), matrix metalloproteinases (MMPs), and metallo-
peptidase tissue inhibitor 1 (TIMP-1) are biologically re-
lated molecules which integrate inflammation, activation
of different immune cells, tissue injury and remodeling, all
events associated to ADD. In fact, CD40L on the surface
of activated T-cells, binds the CD40 receptor of macro-
phages. These cells are then induced to release MMPs, in
particular MMP-1, which promote the initial phase of
vascular extracellular matrix degradation [19, 20]. In nor-
mal conditions, this mechanism is naturally regulated by
TIMP-1 which can balance increased MMPs activities
[21]. Amplification of inflammation is also sustained by
recruitment of other immune cells. In particular, neutro-
phils are recruited in response to endothelial damage and
the increased production of myeloperoxidase (MPO) is a
marker of their activation [22, 23].
To date, AAD diagnosis is based on symptoms, history
and physical examination, electrocardiography, chest X-
rays and imaging studies. No specific biomarkers are
available to increase the speed of diagnosis.
To our knowledge alteration of molecules associated
to endothelial damage during the early stage of AAD have
not been fully explored and for this reason our study should
be considered as a pilot study aimed to evaluate whether
the simultaneous evaluation of circulating levels of CD40L,
MPO and MMP-1,-2,-9 and TIMP-1 could represent a
novel powerful diagnostic tool in timely diagnosis of AAD.
Methods
Patients
We enrolled at I.R.C.C.S. Policlinico San Donato of
Milan 32 male patients (40–86 years of age, mean
62.2 ± 18.6 years) with only non-Marfan AAD to ex-
clude any possible genetic confounding factors, diag-
nosed within 24 h of symptom onset and 30 healthy
age-matched individuals as a control group. AAD
patients were then classified according to Stanford
classification in two groups: type A (n = 22) including pa-
tients in which the dissection involves the ascending aorta
(proximal dissection) and type B (n = 11) including pa-
tients in which the dissection is limited to the descending
aorta (distal dissection). Hospitalized type A AAD patients
underwent to vascular surgery, presented first blood
systolic pressure with average value of 126 mmHg and a
diastolic pressure of 70 mmHg. All type A patients had
history of hypertension and only 2 patients had history of
atherosclerosis. Type A patients were treated with beta
and calcium channel blockers and ACE inhibitors. Hospi-
talized type B AAD patients, underwent to endovascular
management, had a first blood systolic pressure with
average value of 206 mmHg and a diastolic pressure of
120 mmHg with history of atherosclerosis, treated with
nitroprusside drug and calcium channel blockers. Both
type A and B patients have not of prior aortic dissection
and don’t have prior mitral, bicuspid, cuspid and aortic
valve diseases. All patients enrolled in this study weren’t
smokers and don’t have abused of cocaine drug.
The study protocol was approved by local Ethics Com-
mittee (ASL Milano 2) and patients gave their written
informed consent, conducted in accordance with the
Declaration of Helsinki, as revised in 2013.
Experimental
Plasma sample were collected immediately after ospe-
dalization, before the surgery and separated after cen-
trifugation at 1000 g for 15 min and were stored at
−20 °C until analysis. The quantification of CD40L,
MPO, MMP-1,-2,-9 and TIMP-1 and were measured
by enzyme-linked immunosorbent assays (ELISA) ac-
cording to the manufacturer’s directions (Quantakine
Immunoassay, R&D System, Minneapolis, Minnesota).
Statistical analysis
Data were expressed as mean ± standard deviation (SD)
and analyzed by GraphPad Prism 5.0 biochemical stat-
istical package (GraphPad Software, Inc., San Diego,
CA). The normality of data distribution was assessed by
the Kolmogrov-Smirnoff test. Comparison between groups
was performed using Student’s two-tailed unpaired T-test
or Mann-Whitney U-test, as appropriate. A p value < 0.05
was considered statistically significant.
Results
Compared to controls, both type A and B AAD patients
had higher CD40L (p < 0.001) and MPO (p < 0.01) levels
(p < 0.001 for both) and MPO (p < 0.01 for both) (Fig. 1).
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MMP-1 was higher in the overall AAD group (p < 0.01).
After Stanford classification, type A group had increased
level compared both to controls and type B (p < 0.01 and
p < 0.05, respectively). Controls and type B patients were
almost the same (Fig. 1).
TIMP-1 was higher in the overall AAD group, as well
as in both type A and B, compared to controls (p < 0.001
for all).
Any difference was found in MMP-2 and MMP-9
levels nor between controls and AAD patients, nor after
classification (p > 0.05 for all).
Discussion
Our findings indicate that during the acute phase of
aorta dissection within 24 h, compensatory mechanisms
to overcome the endothelial damage result in increase of
the molecules involved in tissue remodeling as well as
the mediators of immune response. Our result shown
that CD40L levels were markedly higher in AAD pa-
tients – aimed at intensifying macrophage and T-cell
recruitment – as proved also by the higher MPO levels
in the same group. This confirm that not only in late
stage but also in the early phase of AAD, the endothe-
lium instability is mediated first by pro-inflammatory
cytokines and chemoattractants T linfocytes. Secondly,
the local induced macrophages are stimulated to release
MMPs aimed to disintegrated extra-cellular products
from endothelial rupture.
Another important point is that the endothelial frag-
mentation of elastin and collagen occurs not only in
Marfan syndrome but also in spontaneous AAD and
MMP and they play a pivotal role in elastin and collagen
digestion and consequently into endothelium turnover
and repair as previously described [19, 24].
Among MMP, it is reported that MMP-1 is the
principal enzyme involved to endothelium remodeling
due to its ability to degrade type I and III collagens
that are the major collagens present in vascular wall.
This assumption is well demonstrated by our results
which highlighted in AAD patients higher levels of
MMP-1 compared to controls.
Contrarily, any statistical differences were observed in
both MMP-2 and MMP-9 levels as expected. This may
be explained by two principal reasons: first MMP work
together but the first enzyme activated by vascular wall
damage is MMP-1 followed by the further cleavage of
MMP-2 and then of the other MMP [19, 24].
Secondly, in addition to the activity of TIMP-1, the
natural inhibitor of MMP and in particular of MMP-9, it
has demonstrated that the levels of MMP-9 aimed to
degrade elastin fragments, can dramatically decrease due
to the massive MMP-1 which can reduce elastin avail-
ability [19]. Therefore we can suggest that MMP-1, well
Fig. 1 Circulating levels of molecules involved into endothelium remodeling in aortic dissection and controls patients. AAD patients have higher
level of CD40L, MPO, TIMP-1, and MMP-1 than controls (p < 0.05). The same trend was also highlighted subdividing AAD patients in type A and B
according to Stanford classification (p < 0.05). No statistically significance was observed in MMP-2 and MMP-9 circulating levels between AAD and
control patients. Between A and B subgroups of ADD patients any statistically significance was observed (p = 0.05)
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recognized to be the principal mediator of vascular
remodeling in overt AAD, can be also an important
marker of AAD in the early stage since its levels change
yet within 24 h of signs and symptoms of this disorder.
Conclusions
Our study is one of the few studies focused on the early
stage of AAD in particular within the 24 h from signs
and symptoms of this disorder. Although previous studies
demonstrated the simultaneous activation and increased
levels of all MMPs and their inhibitor during aortic dissec-
tion, their observations were mainly done after the overt
stage of the dissection, specifically over the 24 h from
signs and symptoms of the disorder and mainly after
surgery.
Contrarily our study was done during the early stage
of the dissection in which MMP-1 is the first MMP that
increase its levels in the early phase of the lesion in
occurrence of CD40L, MPO and TIMP-1 increases.
On the light of this, we finally suggest the simultaneous
evaluation of CD40L, MPO and MMP-1 and TIMP-1 cir-
culating levels as promising diagnostic tool for clinical
assessment in the early phase of AAD although additional
experiments are need to confirm our outcomes.
Abbreviations
AAD: acute aortic dissection; CD40L: CD40 ligand; MPO: myeloperoxidase;
MMP: matrix metalloproteinase; TIMP-1: metallopeptidase tissue inhibitor 1.
Competing interests
The authors declare that the research was conducted in the absence of any
commercial or financial relationships that could be construed as a potential
conflict of interest.
Authors’ contributions
CRMM, TL, ED and EV designed the research study. EV performed the
research and analyzed the data. TS, MTMM and RR enrolled the patients and
stared the clinical study protocol. EV and ED wrote the paper. All authors
critically read and approved the final manuscript.
Acknowledgements
The authors acknowledge the Italian Ministero dell’Istruzione, Università e
Ricerca (MIUR) and Italian Ministero della Salute ( R.C. n° 9.14.2) for providing
founds for this research project. The authors also acknowledge Judit Bagott
for English edit and Dr. Elena Costa for clinical chemistry analysis.
Author details
1Department of Biomedical Sciences for Health, Università degli Studi di
Milano, Via Luigi Mangiagalli 31, 20133 Milan, Italy. 2Laboratory Medicine
Operative Unit-1, Clinical Pathology, I.R.C.C.S. Policlinico, San Donato
Milanese, Milan, Italy. 3Thoracic Aortic Research Center, I.R.C.C.S. Policlinico
San Donato, San Donato Milanese, Milan, Italy.
Received: 22 December 2015 Accepted: 14 March 2016
References
1. Grillo A, Pini A, Marelli S, Gan L, Giuliano A, Trifiro G, Santini F, Salvi L,
Salvi P, Viecca F, Carretta R, Parati G. 5b.05: Marfan Syndrome:
Assessment of Aortic Dissection Risk by Analysis of Aortic Viscoelastic
Properties. J Hypertens. 2015;33 Suppl 1:e67.
2. Kim WH, Bae J, Choi SW, Lee JH, Kim CS, Cho HS, Lee SM. Stanford type A
aortic dissection in a patient with Marfan syndrome during pregnancy:
a case report. Korean J Anesthesiol. 2016;69:76–9.
3. Tromp G, Kuivaniemi H, Hinterseher I, Carey DJ. Novel genetic mechanisms
for aortic aneurysms. Curr Atheroscler Rep. 2010;12:259–66.
4. Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from
heritable conditions. Nature. 2011;473:308–16.
5. Yamada H, Sakata N, Wada H, Tashiro T, Tayama E. Age-related distensibility
and histology of the ascending aorta in elderly patients with acute aortic
dissection. J Biomech. 2015;48:3267–73.
6. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable
cardiovascular risk factor? Hypertension. 2005;46:454–62.
7. Sawabe M, Hamamatsu A, Chida K, Mieno MN, Ozawa T. Age is a major
pathobiological determinant of aortic dilatation: a large autopsy study of
community deaths. J Atheroscler Thromb. 2011;18:157–65.
8. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E,
Zeiher AM, Simoons ML. Soluble CD40 ligand in acute coronary
syndromes. N Engl J Med. 2003;348:1104–11.
9. He R, Guo DC, Estrera AL, Safi HJ, Huynh TT, Yin Z, Cao SN, Lin J, Kurian T,
Buja LM, Geng YJ, Milewicz DM. Characterization of the inflammatory and
apoptotic cells in the aortas of patients with ascending thoracic aortic
aneurysms and dissections. J Thorac Cardiovasc Surg. 2006;131:671–8.
10. Tan J, Hua Q, Gao J, Fan ZX. Clinical implications of elevated serum
interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor
of metalloproteinase-1 in patients with acute ST-segment elevation
myocardial infarction. Clin Cardiol. 2008;31:413–8.
11. Balistreri CR, Pisano C, Candore G, Maresi E, Codispoti M, Ruvolo G. Focus on
the unique mechanisms involved in thoracic aortic aneurysm formation in
bicuspid aortic valve versus tricuspid aortic valve patients: clinical
implications of a pilot study. Eur J Cardiothorac Surg. 2013;43:e180–6.
12. Akiyama M, Ohtani H, Sato E, Nagura H, Tabayashi K. Up-regulation of
matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase
were coupled with that of type I procollagen in granulation tissue response
after the onset of aortic dissection. Virchows Arch. 2006;448:811–21.
13. Wang XJ, Huang B, Yang YM, Zhang L, Su WJ, Tian L, Lu TY, Zhang S, Fan XH,
Hui RT. Differential expression of microRNAs in aortic tissue and plasma in
patients with acute aortic dissection. J Geriatr Cardiol. 2015;12:655–61.
14. Balistreri CR. Genetic contribution in sporadic thoracic aortic aneurysm?
Emerging evidence of genetic variants related to TLR-4-mediated signaling
pathway as risk determinants. Vascul Pharmacol. 2015;74:1–10.
15. Elefteriades JA. Thoracic aortic aneurysm: reading the enemy's playbook.
Curr Probl Cardiol. 2008;33:203–77.
16. Suzuki T, Trimarchi S, Sawaki D, Grassi V, Costa E, Rampoldi V, Nagai R,
Eagle K. Circulating transforming growth factor-beta levels in acute aortic
dissection. J Am Coll Cardiol. 2011;58:775.
17. Luo F, Zhou XL, Li JJ, Hui RT. Inflammatory response is associated with
aortic dissection. Ageing Res Rev. 2009;8:31–5.
18. Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, Rakowski H,
Struyven J, Radegran K, Sechtem U, Taylor J, Zollikofer C, Klein WW,
Mulder B, Providencia LA. Diagnosis and management of aortic dissection.
Eur Heart J. 2001;22:1642–81.
19. Ishii T, Asuwa N. Collagen and elastin degradation by matrix
metalloproteinases and tissue inhibitors of matrix metalloproteinase in
aortic dissection. Hum Pathol. 2000;31:640–6.
20. Schonbeck U, Sukhova GK, Gerdes N, Libby P. T(H)2 predominant immune
responses prevail in human abdominal aortic aneurysm. Am J Pathol.
2002;161:499–506.
21. Mach F, Schonbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of
monocyte/macrophage functions related to acute atheroma complication
by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.
Circulation. 1997;96:396–9.
22. Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet
shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal
sepsis. J Thromb Haemost. 2013;11:1385–98.
23. Choke E, Thompson MM, Dawson J, Wilson WR, Sayed S, Loftus IM, Cockerill
GW. Abdominal aortic aneurysm rupture is associated with increased medial
neovascularization and overexpression of proangiogenic cytokines.
Arterioscler Thromb Vasc Biol. 2006;26:2077–82.
24. Galliera E, Tacchini L, Corsi Romanelli MM. Matrix metalloproteinases as
biomarkers of disease: updates and new insights. Clin Chem Lab Med.
2015;53:349–55.
Vianello et al. Immunity & Ageing  (2016) 13:9 Page 4 of 4
